Cellebrite DI (CLBT) Competitor Comparison
We are evaluating the key criteria listed to compare Cellebrite DI (CLBT) against its competitors in the Software - Infrastructure industry.
Market Capitalization
63 / 113Gross Profits
71 / 98Total Revenue
79 / 108EBITDA
47 / 107Free Cashflow
101 / 105Quick Ratio
56 / 108Earnings per Share
95 / 108Dividend yield
0 / 9Total Cash
59 / 108Performance 3 years
9 / 113Performance 5 years
23 / 113Performance 10 years
37 / 113Linearity 3 years
109 / 113Linearity 5 years
101 / 113Linearity 10 years
91 / 113Total Rank
72 / 113Dividend Rank
20 / 113Valuation Rank
14 / 113Piotroski Rank
46 / 113Muliplier Rank
113 / 113Piotroski Rank - CLBT ranking 46 / 113
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.